Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study. // Cancer Cell. – URL: https://www.sciencedirect.com/science/article/pii/S1535610826004782?dgcid=rss_sd_all
Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study. Cancer Cell. https://www.sciencedirect.com/science/article/pii/S1535610826004782?dgcid=rss_sd_all
“Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study.” Cancer Cell.
@article{article1911,
title = {Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study},
journal = {Cancer Cell},
url = {https://www.sciencedirect.com/science/article/pii/S1535610826004782?dgcid=rss_sd_all}
}